...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Debt

narmac, as long as the lights stay on, we remain in business! That's as much as we can hope for under the present circumstances, to inch us closer to several finish lines.

Narmac just keep on buying "ZHCLF" @ $0.15 CAN. With Zenith's Oncology pipeline that's a real bargain. I'm doing it.

https://clinicaltrials.gov/ct2/show/NCT04840589

https://clinicaltrials.gov/ct2/show/NCT04986423#contacts

https://clinicaltrials.gov/ct2/show/NCT03901469

https://clinicaltrials.gov/ct2/show/NCT04471974

https://clinicaltrials.gov/ct2/show/NCT03051659

https://clinicaltrials.gov/ct2/show/NCT05111561

 

 

GLTA

Koo

Share
New Message
Please login to post a reply